William Pelham to Treatment Outcome
This is a "connection" page, showing publications William Pelham has written about Treatment Outcome.
Connection Strength
2.455
-
Barney S, Sibley MH, Coxe SJ, Meinzer MC, Pelham WE. High Versus Low Intensity Summer Adolescent ADHD Treatment Effects on Internalizing, Social, and Self-Esteem Problems. J Clin Child Adolesc Psychol. 2024 May-Jun; 53(3):389-396.
Score: 0.156
-
Pelham WE, Altszuler AR, Merrill BM, Raiker JS, Macphee FL, Ramos M, Gnagy EM, Greiner AR, Coles EK, Connor CM, Lonigan CJ, Burger L, Morrow AS, Zhao X, Swanson JM, Waxmonsky JG, Pelham WE. The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. J Consult Clin Psychol. 2022 May; 90(5):367-380.
Score: 0.155
-
Merrill BM, Raiker JS, Evans SW, Gnagy EM, Pelham WE. Cognitive mechanisms of methylphenidate in ADHD: Do improvements in sustained attention mediate behavioral improvements in the natural environment? Child Neuropsychol. 2021 05; 27(4):425-446.
Score: 0.142
-
Campez M, Raiker JS, Little K, Altszuler AR, Merrill BM, Macphee FL, Gnagy EM, Greiner AR, Musser ED, Coles EK, Pelham WE. An evaluation of the effect of methylphenidate on working memory, time perception, and choice impulsivity in children with ADHD. Exp Clin Psychopharmacol. 2022 Apr; 30(2):209-219.
Score: 0.142
-
Waxmonsky JG, Pelham WE, Campa A, Waschbusch DA, Li T, Marshall R, Babocsai L, Humphery H, Gnagy E, Swanson J, Hanc T, Fallahazad N, Pelham WE. A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants. J Am Acad Child Adolesc Psychiatry. 2020 12; 59(12):1330-1341.
Score: 0.129
-
Merrill BM, Molina BSG, Coxe S, Gnagy EM, Altszuler AR, Macphee FL, Morrow AS, Trucco EM, Pelham WE. Functional Outcomes of Young Adults with Childhood ADHD: A Latent Profile Analysis. J Clin Child Adolesc Psychol. 2020 Mar-Apr; 49(2):215-228.
Score: 0.124
-
Merrill BM, Morrow AS, Altszuler AR, Macphee FL, Gnagy EM, Greiner AR, Coles EK, Raiker JS, Coxe S, Pelham WE. Improving homework performance among children with ADHD: A randomized clinical trial. J Consult Clin Psychol. 2017 Feb; 85(2):111-122.
Score: 0.105
-
Beery SH, Quay HC, Pelham WE. Differential Response to Methylphenidate in Inattentive and Combined Subtype ADHD. J Atten Disord. 2017 01; 21(1):62-70.
Score: 0.104
-
Pelham WE, Smith BH, Evans SW, Bukstein O, Gnagy EM, Greiner AR, Sibley MH. The Effectiveness of Short- and Long-Acting Stimulant Medications for Adolescents With ADHD in a Naturalistic Secondary School Setting. J Atten Disord. 2017 01; 21(1):40-45.
Score: 0.104
-
Pelham WE, Fabiano GA, Waxmonsky JG, Greiner AR, Gnagy EM, Pelham WE, Coxe S, Verley J, Bhatia I, Hart K, Karch K, Konijnendijk E, Tresco K, Nahum-Shani I, Murphy SA. Treatment Sequencing for Childhood ADHD: A Multiple-Randomization Study of Adaptive Medication and Behavioral Interventions. J Clin Child Adolesc Psychol. 2016 Jul-Aug; 45(4):396-415.
Score: 0.101
-
Waxmonsky JG, Waschbusch DA, Belin P, Li T, Babocsai L, Humphery H, Pariseau ME, Babinski DE, Hoffman MT, Haak JL, Mazzant JR, Fabiano GA, Pettit JW, Fallahazad N, Pelham WE. A Randomized Clinical Trial of an Integrative Group Therapy for Children With Severe Mood Dysregulation. J Am Acad Child Adolesc Psychiatry. 2016 Mar; 55(3):196-207.
Score: 0.100
-
Helseth SA, Waschbusch DA, Gnagy EM, Onyango AN, Burrows-MacLean L, Fabiano GA, Coles EK, Chacko A, Wymbs BT, Walker KS, Wymbs FA, Garefino A, Massetti GM, Robb Mazzant J, Hoffman MT, Waxmonsky JG, Nichols-Lopez K, Pelham WE. Effects of behavioral and pharmacological therapies on peer reinforcement of deviancy in children with ADHD-only, ADHD and conduct problems, and controls. J Consult Clin Psychol. 2015 Apr; 83(2):280-292.
Score: 0.093
-
Chacko A, Wymbs BT, Chimiklis A, Wymbs FA, Pelham WE. Evaluating a comprehensive strategy to improve engagement to group-based behavioral parent training for high-risk families of children with ADHD. J Abnorm Child Psychol. 2012 Nov; 40(8):1351-62.
Score: 0.080
-
Waxmonsky JG, Wymbs FA, Pariseau ME, Belin PJ, Waschbusch DA, Babocsai L, Fabiano GA, Akinnusi OO, Haak JL, Pelham WE. A novel group therapy for children with ADHD and severe mood dysregulation. J Atten Disord. 2013 Aug; 17(6):527-41.
Score: 0.077
-
Pelham WE, Waschbusch DA, Hoza B, Gnagy EM, Greiner AR, Sams SE, Vallano G, Majumdar A, Carter RL. Music and video as distractors for boys with ADHD in the classroom: comparison with controls, individual differences, and medication effects. J Abnorm Child Psychol. 2011 Nov; 39(8):1085-98.
Score: 0.075
-
Waxmonsky JG, Waschbusch DA, Akinnusi O, Pelham WE. A comparison of atomoxetine administered as once versus twice daily dosing on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Feb; 21(1):21-32.
Score: 0.071
-
Pelham WE, Waxmonsky JG, Schentag J, Ballow CH, Panahon CJ, Gnagy EM, Hoffman MT, Burrows-MacLean L, Meichenbaum DL, Forehand GL, Fabiano GA, Tresco KE, Lopez-Williams A, Coles EK, Gonz?lez MA. Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting. J Atten Disord. 2011 Jan; 15(1):28-35.
Score: 0.068
-
Pelham WE, Manos MJ, Ezzell CE, Tresco KE, Gnagy EM, Hoffman MT, Onyango AN, Fabiano GA, Lopez-Williams A, Wymbs BT, Caserta D, Chronis AM, Burrows-Maclean L, Morse G. A dose-ranging study of a methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005 Jun; 44(6):522-9.
Score: 0.048
-
Pelham WE, Burrows-Maclean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Exp Clin Psychopharmacol. 2005 May; 13(2):111-26.
Score: 0.048
-
Fosco WD, Rosch KS, Waxmonsky JG, Pelham WE, Hawk LW. Baseline performance moderates stimulant effects on cognition in youth with ADHD. Exp Clin Psychopharmacol. 2021 Aug; 29(4):302-307.
Score: 0.034
-
Sibley MH, Graziano PA, Kuriyan AB, Coxe S, Pelham WE, Rodriguez L, Sanchez F, Derefinko K, Helseth S, Ward A. Parent-teen behavior therapy + motivational interviewing for adolescents with ADHD. J Consult Clin Psychol. 2016 Aug; 84(8):699-712.
Score: 0.026
-
Rosch KS, Fosco WD, Pelham WE, Waxmonsky JG, Bubnik MG, Hawk LW. Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder. J Abnorm Child Psychol. 2016 Feb; 44(2):309-21.
Score: 0.025
-
Baweja R, Belin PJ, Humphrey HH, Babocsai L, Pariseau ME, Waschbusch DA, Hoffman MT, Akinnusi OO, Haak JL, Pelham WE, Waxmonsky JG. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School. J Child Adolesc Psychopharmacol. 2016 Mar; 26(2):154-63.
Score: 0.025
-
Lu X, Nahum-Shani I, Kasari C, Lynch KG, Oslin DW, Pelham WE, Fabiano G, Almirall D. Comparing dynamic treatment regimes using repeated-measures outcomes: modeling considerations in SMART studies. Stat Med. 2016 May 10; 35(10):1595-615.
Score: 0.025
-
Molina BS, Hinshaw SP, Eugene Arnold L, Swanson JM, Pelham WE, Hechtman L, Hoza B, Epstein JN, Wigal T, Abikoff HB, Greenhill LL, Jensen PS, Wells KC, Vitiello B, Gibbons RD, Howard A, Houck PR, Hur K, Lu B, Marcus S. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013 Mar; 52(3):250-63.
Score: 0.020
-
Fabiano GA, Pelham WE, Cunningham CE, Yu J, Gangloff B, Buck M, Linke S, Gormley M, Gera S. A waitlist-controlled trial of behavioral parent training for fathers of children with ADHD. J Clin Child Adolesc Psychol. 2012; 41(3):337-45.
Score: 0.019
-
Sibley MH, Smith BH, Evans SW, Pelham WE, Gnagy EM. Treatment response to an intensive summer treatment program for adolescents with ADHD. J Atten Disord. 2012 Aug; 16(6):443-8.
Score: 0.019
-
Sibley MH, Pelham WE, Mazur A, Gnagy EM, Ross JM, Kuriyan AB. The effect of video feedback on the social behavior of an adolescent with ADHD. J Atten Disord. 2012 Oct; 16(7):579-88.
Score: 0.018
-
Haas SM, Waschbusch DA, Pelham WE, King S, Andrade BF, Carrey NJ. Treatment response in CP/ADHD children with callous/unemotional traits. J Abnorm Child Psychol. 2011 May; 39(4):541-52.
Score: 0.018
-
Waschbusch DA, Cunningham CE, Pelham WE, Rimas HL, Greiner AR, Gnagy EM, Waxmonsky J, Fabiano GA, Robb JA, Burrows-Maclean L, Scime M, Hoffman MT. A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD. J Clin Child Adolesc Psychol. 2011; 40(4):546-61.
Score: 0.018
-
Waxmonsky JG, Waschbusch DA, Pelham WE, Draganac-Cardona L, Rotella B, Ryan L. Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010 Nov; 71(11):1535-51.
Score: 0.017
-
Langberg JM, Arnold LE, Flowers AM, Epstein JN, Altaye M, Hinshaw SP, Swanson JM, Kotkin R, Simpson S, Molina BS, Jensen PS, Abikoff H, Pelham WE, Vitiello B, Wells KC, Hechtman L. Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol. 2010; 39(2):220-33.
Score: 0.017
-
Shiels K, Hawk LW, Reynolds B, Mazzullo RJ, Rhodes JD, Pelham WE, Waxmonsky JG, Gangloff BP. Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol. 2009 Oct; 17(5):291-301.
Score: 0.016
-
King S, Waschbusch DA, Pelham WE, Frankland BW, Corkum PV, Jacques S. Subtypes of aggression in children with attention deficit hyperactivity disorder: medication effects and comparison with typical children. J Clin Child Adolesc Psychol. 2009 Sep; 38(5):619-29.
Score: 0.016
-
King S, Waschbusch DA, Pelham WE, Frankland BW, Andrade BF, Jacques S, Corkum PV. Social information processing in elementary-school aged children with ADHD: medication effects and comparisons with typical children. J Abnorm Child Psychol. 2009 May; 37(4):579-89.
Score: 0.016
-
Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry. 2009 May; 48(5):501-510.
Score: 0.016
-
Yamashita Y, Mukasa A, Honda Y, Anai C, Kunisaki C, Koutaki J, Motoyama S, Miura N, Sugimoto A, Ohya T, Nakashima M, Nagamitsu S, Gnagy EM, Greiner AR, Pelham WE, Matsuishi T. Short-term effect of American summer treatment program for Japanese children with attention deficit hyperactivity disorder. Brain Dev. 2010 Feb; 32(2):115-22.
Score: 0.015
-
Fabiano GA, Pelham WE, Coles EK, Gnagy EM, Chronis-Tuscano A, O'Connor BC. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2009 Mar; 29(2):129-40.
Score: 0.015
-
Fabiano GA, Chacko A, Pelham WE, Robb J, Walker KS, Wymbs F, Sastry AL, Flammer L, Keenan JK, Visweswaraiah H, Shulman S, Herbst L, Pirvics L. A comparison of behavioral parent training programs for fathers of children with attention-deficit/hyperactivity disorder. Behav Ther. 2009 Jun; 40(2):190-204.
Score: 0.015
-
Palumbo DR, Sallee FR, Pelham WE, Bukstein OG, Daviss WB, McDERMOTT MP. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):180-188.
Score: 0.014
-
Chacko A, Wymbs BT, Flammer-Rivera LM, Pelham WE, Walker KS, Arnold FW, Visweswaraiah H, Swanger-Gagne M, Girio EL, Pirvics LL, Herbst L. A pilot study of the feasibility and efficacy of the Strategies to Enhance Positive Parenting (STEPP) program for single mothers of children with ADHD. J Atten Disord. 2008 Nov; 12(3):270-80.
Score: 0.014
-
Swanson JM, Hinshaw SP, Arnold LE, Gibbons RD, Marcus S, Hur K, Jensen PS, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Pelham WE, Wells KC, Conners CK, March JS, Elliott GR, Epstein JN, Hoagwood K, Hoza B, Molina BSG, Newcorn JH, Severe JB, Wigal T. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1003-1014.
Score: 0.014
-
Molina BSG, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, Hechtman L, Jensen PS, Vitiello B, Hoza B, Pelham WE, Elliott GR, Wells KC, Abikoff HB, Gibbons RD, Marcus S, Conners CK, Epstein JN, Greenhill LL, March JS, Newcorn JH, Severe JB, Wigal T. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1028-1040.
Score: 0.014
-
Mrug S, Hoza B, Pelham WE, Gnagy EM, Greiner AR. Behavior and peer status in children with ADHD: continuity and change. J Atten Disord. 2007 May; 10(4):359-71.
Score: 0.014
-
Marshal MP, Molina BS, Pelham WE, Cheong J. Attention-deficit hyperactivity disorder moderates the life stress pathway to alcohol problems in children of alcoholics. Alcohol Clin Exp Res. 2007 Apr; 31(4):564-74.
Score: 0.014
-
Epstein JN, Conners CK, Hervey AS, Tonev ST, Arnold LE, Abikoff HB, Elliott G, Greenhill LL, Hechtman L, Hoagwood K, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Wells K, Vitiello B, Wigal T. Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry. 2006 May; 47(5):446-56.
Score: 0.013
-
Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry. 2005 Sep; 162(9):1628-36.
Score: 0.012
-
Waschbusch DA, Pelham WE, Massetti G. The Behavior Education Support and Treatment (BEST) school intervention program: pilot project data examining schoolwide, targeted-school, and targeted-home approaches. J Atten Disord. 2005 Aug; 9(1):313-22.
Score: 0.012
-
Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol. 2003 Jun; 71(3):540-52.
Score: 0.010
-
Rieppi R, Greenhill LL, Ford RE, Chuang S, Wu M, Davies M, Abikoff HB, Arnold LE, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry. 2002 Mar; 41(3):269-77.
Score: 0.010